128 related articles for article (PubMed ID: 28228691)
1. Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma.
Hu H; Wang Y; Li Z; Zhu Y; Zhang W; Wang D; Lin T; Yang J; Wang Y; Cheng J
Cancer Cell Int; 2017; 17():26. PubMed ID: 28228691
[TBL] [Abstract][Full Text] [Related]
2. CBX3/HP1γ is upregulated in tongue squamous cell carcinoma and is associated with an unfavorable prognosis.
Zhang H; Fu X; Su X; Yang A
Exp Ther Med; 2018 May; 15(5):4271-4276. PubMed ID: 29731822
[TBL] [Abstract][Full Text] [Related]
3. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma.
Hu F; Chen X; Liu X; Wang C; Lv L; Xie N; Wang T; Huang H
Oncol Lett; 2015 Sep; 10(3):1303-1308. PubMed ID: 26622668
[TBL] [Abstract][Full Text] [Related]
6. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
7. BASP1 is up-regulated in tongue squamous cell carcinoma and associated with a poor prognosis.
Li Y; Wu T; Jiao Z; Yang A
Asian J Surg; 2022 May; 45(5):1101-1106. PubMed ID: 34531104
[TBL] [Abstract][Full Text] [Related]
8. Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma.
Chen HC; Tseng YK; Shu CW; Weng TJ; Liou HH; Yen LM; Hsieh IC; Wang CC; Wu PC; Shiue YL; Fu TY; Tsai KW; Ger LP; Liu PF
J Oral Pathol Med; 2019 Jul; 48(6):468-476. PubMed ID: 30972812
[TBL] [Abstract][Full Text] [Related]
9. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
[TBL] [Abstract][Full Text] [Related]
10. Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma.
Wu K; Wei J; Liu Z; Yu B; Yang X; Zhang C; Abdelrehem A; Zhang C; Li S
BMC Cancer; 2019 Jul; 19(1):714. PubMed ID: 31324174
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer.
Yuan C; Li Z; Wang Y; Qi B; Zhang W; Ye J; Wu H; Jiang H; Song LN; Yang J; Cheng J
Histopathology; 2014 Nov; 65(5):595-605. PubMed ID: 24762230
[TBL] [Abstract][Full Text] [Related]
12. High expression of FMNL3 associates with cancer cell migration, invasion, and unfavorable prognosis in tongue squamous cell carcinoma.
Liu J; Chen S; Chen Y; Geng N; Feng C
J Oral Pathol Med; 2019 Jul; 48(6):459-467. PubMed ID: 30955218
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
15. CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.
Chen Y; Tian T; Mao MJ; Deng WY; Li H
BMC Cancer; 2018 May; 18(1):514. PubMed ID: 29720147
[TBL] [Abstract][Full Text] [Related]
16. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma.
Zhang H; Chen W; Fu X; Su X; Yang A
Gene; 2018 May; 654():49-56. PubMed ID: 29462646
[TBL] [Abstract][Full Text] [Related]
17. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of proline rich 11 is an independent unfavorable prognostic factor for survival of tongue squamous cell carcinoma patients.
Wang C; Yu L; Hu F; Wang J; Chen X; Tai S; Cheng B
Oncol Lett; 2017 Oct; 14(4):4527-4534. PubMed ID: 29085449
[TBL] [Abstract][Full Text] [Related]
19. Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma.
Liu PF; Chen HC; Shu CW; Sie HC; Lee CH; Liou HH; Cheng JT; Tsai KW; Ger LP
Clin Oral Investig; 2020 Aug; 24(8):2673-2682. PubMed ID: 31707626
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
